Despite Evidence, the WHO Ignores Treatments for COVID-19

By Novikov Aleksey @ Shutterstock.com

On his blog, Dr. Joseph Mercola explores why the WHO and other health organizations have ignored treatments for COVID-19 that appear to work. He writes:

While the list of crimes committed by authorities during the COVID-19 pandemic is a long one, perhaps the biggest crime of all is the purposeful suppression of safe and effective treatments. At this point, it seems quite clear that this was done to protect the COVID jab rollout.

The COVID shots were brought to market under emergency use authorization (EUA), which can only be obtained if there are no other alternatives available. In a sane world, the COVID gene therapies would never have gotten an EUA, as there are several safe and effective treatment options available.

One treatment that stands out above the others is ivermectin, a decades-old antiparasitic drug that is on the World Health Organization’s list of essential medications.

What makes ivermectin particularly useful in COVID-19 is the fact that it works both in the initial viral phase of the illness, when antivirals are required, as well as the inflammatory stage, when the viral load drops off and anti-inflammatories become necessary. It’s been shown to significantly inhibit SARS-CoV-2 replication in vitro,¹ speed up viral clearance and dramatically reduce the risk of death.

Gold Standard Review Supports Use of Ivermectin

Dr. Tess Lawrie, a medical doctor, Ph.D., researcher and director of Evidence-Based Medicine Consultancy Ltd (video above).² in the U.K., has been trying to get the word out about ivermectin. To that end, she helped organize the British Ivermectin Recommendation Development (BIRD) panel³ and the International Ivermectin for COVID Conference,⁴ which was held online, April 24, 2021.

Twelve medical experts⁵ from around the world shared their knowledge during this conference, reviewing mechanism of action, protocols for prevention and treatment, including so-called long-hauler syndrome, research findings and real world data. All of the lectures, which were recorded via Zoom, can be viewed on Bird-Group.org.⁶

Lawrie has published several systematic reviews and meta-analyses of studies looking at ivermectin for the prevention and treatment of COVID-19 infection. A rapid review performed on behalf of the Front Line COVID-19 Critical Care Alliance (FLCCC) in the U.S., January 3, 2021, found the drug “probably reduces deaths by an average 83% compared to no ivermectin treatment.”⁷

Her February 2021 meta-analysis, which included 13 studies, found a 68% reduction in deaths. This is an underestimation of the beneficial effect, because one of the studies included used hydroxychloroquine (HCQ) in the control arm. Since HCQ is an active treatment that has also been shown to have a positive impact on outcomes, it’s not surprising that this particular study did not rate ivermectin as better than the control treatment (which was HCQ).

Two months later, March 31, 2021, Lawrie published an updated analysis that included two additional randomized controlled trials. This time, the mortality reduction was 62%. When four studies with high risk of bias were removed during a subsequent sensitivity analysis, they ended up with a 72% reduction in deaths.

(Sensitivity analyses are done to double-check and verify results. Since the sensitivity analysis rendered an even better result, it confirms the initial finding. In other words, ivermectin is unlikely to reduce mortality by anything less than 62%.)

Lawrie reviewed the February and March analyses and other meta-analyses in an interview with Dr. John Campbell, featured in “More Good News on Ivermectin.” Lawrie has now published her third systematic review. According to this paper, published June 17, 2021 in the American Journal of Therapeutics:⁸

“Meta-analysis of 15 trials found that ivermectin reduced risk of death compared to no ivermectin (average risk ratio 0.38 …) … Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% … Secondary outcomes provided less certain evidence.

Low-certainly evidence suggested that there may be no benefit with ivermectin for ‘need for mechanical ventilation,’ whereas effect estimates for ‘improvement’ and ‘deterioration’ clearly favored ivermectin use. Severe adverse events were rare among treatment trials …”

World Health Organization Refuses to Recommend Ivermectin

Despite the fact that most of the evidence favors ivermectin, when the WHO finally updated its guidance on ivermectin at the end of March 2021,^9,10 they largely rejected it, saying more data are needed. They only recommend it for patients who are enrolled in a clinical trial.

Yet, they based their negative recommendation on a review that included just five studies, which still ended up showing a 72% reduction in deaths. What’s more, in the WHO’s summary of findings, they suddenly include data from seven studies, which combined show an 81% reduction in deaths. The confidence interval is also surprisingly high, with a 64% reduction in deaths on the low end, and 91% on the high end.

Even more remarkable, their absolute effect estimate for standard of care is 70 deaths per 1,000, compared to just 14 deaths per 1,000 when treating with ivermectin. That’s a reduction in deaths of 56 per 1,000 when using the drug. The confidence interval is between 44 and 63 fewer deaths per 1,000.

Despite that, the WHO refuses to recommend this drug for COVID-19. Rabindra Abeyasinghe, a WHO representative to the Philippines, commented that using ivermectin without “strong” evidence is “harmful” because it can give “false confidence” to the public.¹¹

The following two tabs change content below.

• Bio
• Latest Posts

E.J. Smith - Your Survival Guy

E.J. Smith is Founder of YourSurvivalGuy.com, Managing Director at Richard C. Young & Co., Ltd., a Managing Editor of Richardcyoung.com, and Editor-in-Chief of Youngresearch.com. His focus at all times is on preparing clients and readers for “Times Like These.” E.J. graduated from Babson College in Wellesley, Massachusetts, with a B.S. in finance and investments. In 1995, E.J. began his investment career at Fidelity Investments in Boston before joining Richard C. Young & Co., Ltd. in 1998. E.J. has trained at Sig Sauer Academy in Epping, NH. His first drum set was a 5-piece Slingerland with Zildjians. He grew-up worshiping Neil Peart (RIP) of the band Rush, and loves the song Tom Sawyer—the name of his family’s boat, a Grady-White Canyon 306. He grew up in Mattapoisett, MA, an idyllic small town on the water near Cape Cod. He spends time in Newport, RI and Bartlett, NH—both as far away from Wall Street as one could mentally get. The Newport office is on a quiet, tree lined street not far from the harbor and the log cabin in Bartlett, NH, the “Live Free or Die” state, sits on the edge of the White Mountain National Forest. He enjoys spending time in Key West (RIP JB) and Paris. Please get in touch with E.J. at ejsmith@yoursurvivalguy.com To sign up for my free monthly Survive & Thrive letter, click here.

Latest posts by E.J. Smith - Your Survival Guy (see all)

• “Then One Day the Grandfather was Gone” - September 28, 2023
• How Joe Biden Raised Oil Prices - September 28, 2023
• Is the Philadelphia Looting Spree the Wake-up Call America Needs? - September 28, 2023
• “No Way I’m Spending That Much on Those” - September 27, 2023
• What Trade Policy Serves America’s National Interest Best? - September 27, 2023